Summary
The role of nephron-sparing surgery for renal cell carcinoma is well established in patients with an anatomical or functional solitary kidney (imperative indication) in which a radical nephrectomy would render the patient anephric with subsequent need for hemodialysis. This also encompasses patients with a unilateral renal cell carcinoma and a functioning contralateral kidney when the opposite renal unit is affected by a disease that might threaten its future function, such as renal artery stenosis, chronic pyelonephritis, stone disease or systemic conditions such as diabetes. A functioning renal remant of at least 20% of normal renal parenchyma seems to be necessary to avoid end-stage renal failure in these patients [16]. There have been several reports in the literature of excellent 5-year cancer-specific survival rates of over 80% in such circumstances [12, 15]. These results were confirmed in our institution, with a 5-year cancer-specific survival rate of 83% in over 70 patients with an imperative indication for nephron-sparing surgery. Thereby the prognosis was significantly influenced by the local tumor stage and the grade of malignancy. These data support the efficacy of nephron-sparing surgery in this clinical situation.
Similar content being viewed by others
References
Blackley SK, Lagada L, Woolfitt RA, Schellhammer PF (1988) Ex situ study of the effectivenss of enucleation in patients with renal cell carcinoma. J Urol 140:6–10
Butler BP, Novick AC, Miller DP, Campbell SA, Licht MR (1995) Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology 45:34–41
Cheng WS, Farrow GM, Zincke H (1991) The incidence of multicentricity in renal cell carcinoma. J Urol 146:1221–1223
Horton WA, Wong V, Eldridge R (1976) Von Hippel-Lindau disease. Arch Intern Med 136:769–777
Kauczor HU, Schadmand-Fischer S, Filipas D, Schwickert HC, Steinbach F, Schild HH, Thelen M (1994) CT after enucleation of renal cell carcinoma. Abdom Imaging 19:361–365
Licht MR, Novick AC (1993) Nephron-sparing surgery for renal cell carcinoma. J Urol 149:1–7
Licht MR, Novick AC, Goormastic M (1994) Nephron-sparing surgery in incidental versus suspected renal cell carcinoma. J Urol 152:39–44
Maher ER, Yates JRW, Harries R, Benjamin C, Moore AT, Ferguson-Smith MA (1990) Clinical features and natural history of Hippel-Lindau disease. Q J Med 238:1151–1163
Marberger M, Pugh RCB, Auvert J (1981) Conservative surgery of renal carcinoma: the EIRSS experience. Br J Urol 53:528–532
Melmon KL, Rosen SW (1964) Lindau's disease: review of the literature and study of a large kindred. Am J Med 36:595–560
Moll V, Becht E, Ziegler M (1993) Kidney preserving surgery in renal cell tumors: Indications, techniques and results in 152 patients. J Urol 150:319–323
Morgan WR, Zincke H (1990) Progression and survival after renal conserving surgery for renal cell carcinoma: experience in 104 patients and extended follow-up. J Urol 144:852–858
Mukamel E, Konichezky M, Engelstein D, Servadio C (1988) Incidental small renal tumors accompanying clinically overt renal cell carcinoma. J Urol 140:22–24
Novick AC (1987) Partial nephrectomy for renal cell carcinoma. Urol Clin N Am 14:419
Novick AC, Streem S, Montie JE, et al (1989) Conservative surgery in renal cell carcinoma: A single-center experience with 100 patients. J Urol 141:835–839
Novick AC, Gephardt G, Guz B, et al (1991) Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 325:1058–1062
Penn I (1993) The effect of immunosuppression on pre-existing cancers. Transplantation 55:742–747
Petritsch PH, Rauchenwald M, Zechner O, Ludvik W, Pummer K, Urlesberger H, Eberle J, Joos H, Kaufmann F, Kugler W, Desristoforo A, Dittel EE (1990) Results after organ-preserving surgery for renal cell carcinoma. An Austrian multicenter study. Eur Urol 18:84–87
Rosenthal CL, Kraft R, Zingg E (1984) Organ-preserving surgery in renal cell carcinoma: tumor enucleation versus partial kidney resection. Eur Urol 10:222–228
Solomon D, Schwarz A (1988) Renal pathology in von Hippel-Lindau disease. Hum Pathol 19:1072–1079
Steinbach F, Stöckle M, Müller SC, Thüroff JW, Melchior SW, Stein R, Hohenfellner R (1992) Conservative surgery of renal cell tumors in 140 patients: 21 years of experience. J Urol 148:24–30
Steinbach F, Stöckle M, Griesinger A, Störkel S, Stein R, Miller DP, Hohenfellner R (1994) Multifocal renal cell tumors: a retrospective analysis of 56 patients with radical nephrectomy. J Urol 152:1393–1396
Steinbach F, Novick AC, Shoskes D (1994) Renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. Urology 44:760–763
Steinbach F, Novick AC, Zincke MD, Miller DP, Williams RD, Lund G, Skinner DG, Esrig D, Richie JP, deKemion JB, Marshall F, Marsh CL (in press) Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol
Stephens R, Graham SD (1990) Enucleation of tumor versus partial nephrectomy as conservative treatment of renal cell carcinoma. Cancer 65:2663–2667
Tosaka A, Ohya K, Yamada K, et al (1990) Incidence and properties of renal masses and asymptomatic renal cell carcinoma detected by abdominal ultrasonography. J Urol 144:1097–1099
Tsukamoto T, Kumamoto Y, Yamazaki K, et al (1991) Clinical analysis of incidentally found renal cell carcinoma. Eur Urol 19:109–113
Van Poppel H, Claes H, Willemen P, Oyen R, Baert L (1991) Is there a place for conservative surgery in the treatment of renal cell carcinoma? Br J Urol 67:129–133
Van Poppel H, Baert L (1994) Elective conservative surgery for renal cell carcinoma (AUA update series, lesson 31) 13:246–251
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steinbach, F., Stöckle, M. & Hohenfellner, R. Current controversies in nephron-sparing surgery for renal-cell carcinoma. World J Urol 13, 163–165 (1995). https://doi.org/10.1007/BF00184872
Issue Date:
DOI: https://doi.org/10.1007/BF00184872